Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zai Lab (ZLAB) Shares Issued (2020 - 2025)

Zai Lab's Shares Issued history spans 6 years, with the latest figure at $249000.0 for Q4 2025.

  • For Q4 2025, Shares Issued fell 99.88% year-over-year to $249000.0; the TTM value through Dec 2025 reached $13.7 million, down 93.71%, while the annual FY2025 figure was $13.7 million, 93.71% down from the prior year.
  • Shares Issued for Q4 2025 was $249000.0 at Zai Lab, down from $2.0 million in the prior quarter.
  • Across five years, Shares Issued topped out at $814.9 million in Q3 2021 and bottomed at -$811.5 million in Q4 2021.
  • The 5-year median for Shares Issued is $1.0 million (2022), against an average of $12.5 million.
  • The largest YoY upside for Shares Issued was 80741.47% in 2021 against a maximum downside of 171.58% in 2021.
  • A 5-year view of Shares Issued shows it stood at -$811.5 million in 2021, then skyrocketed by 99.3% to -$5.6 million in 2022, then skyrocketed by 66.33% to -$1.9 million in 2023, then soared by 11475.93% to $216.0 million in 2024, then crashed by 99.88% to $249000.0 in 2025.
  • Per Business Quant, the three most recent readings for ZLAB's Shares Issued are $249000.0 (Q4 2025), $2.0 million (Q3 2025), and $8.4 million (Q2 2025).